Pharmacogenetic Testing for Warfarin Advances
Pharmacogenetics has the potential to avoid some of the three quarter million adverse drug events seen each year.
Read More
Search Results for: lung cancer
Exosome Diagnostics and DxS Collaborate to Develop Blood Based Tests for Key Cancer Mutations
Exosome Diagnostics Inc and DxS Ltd today announced that they will collaborate on the development of blood based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR.
Read MoreSCC Soft Computer passes Cancer Care Ontario Vendor Certification
SCC Soft Computer announces that their SoftPath synoptic reporting tool has been certified by Cancer Care Ontario.
Read MorePrometheus Presents Proprietary Oncology Diagnostic Platform
Prometheus Laboratories Inc, a specialty pharmaceutical and diagnostic company, presented an overview of its proprietary oncology diagnostic platform yesterday at the American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Fla.
Read MoreInflammation Markers in Breast Cancer Survivors Linked to Survival
A study led by researchers at Fred Hutchinson Cancer Research Center has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast cancer patients.
Read More